To expand the tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To expand the tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Agriculture.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section idc533c124c81048f6b66351046ab83450: 1. Expanding the tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis Section 524(a)(3) of the...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
This bill, To expand the tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Agriculture
Primary Purpose
This bill, To expand the tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
Contextual inference, no direct clause citation- health care providers and patients
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- federal implementing agencies
- health care providers and patients
Contextual inference, no direct clause citation
Sponsors
Mark Kelly
D-AZ | Primary Sponsor
Legislative Progress
IntroducedMr. Kelly (for himself and Ms. Sinema) introduced the following …
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "federal_implementing_agencies"
- → Federal agencies assigned duties by the bill
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology